Skip to main content
. 2016 Jun 7;24(2):117–128. doi: 10.3727/096504016X14612603423511

Figure 8.

Figure 8

Comparison of OS and PFS of patients treated by bevacizumab. (a) Comparison of PFS; (b) comparison of OS. (A) Experimental group and (B) TEM+RAD group.